IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Wei, Hongen ^a,b   Zou, Hua ^a,c   Sheikh, Ashfaq M ^a   Malik, Mazhar ^a   Dobkin, Carl ^a   Brown, W Ted ^a   Li, Xiaohong ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Autism cytokines; Inflammation; Neural adhesion and migration; Synapse development

Indexed keywords

INTERLEUKIN 6; HYBRID PROTEIN;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTISM; CELL ADHESION; CELL MIGRATION; CEREBELLUM; CONTROLLED STUDY; DENDRITIC SPINE; GENE TARGETING; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYNAPTIC TRANSMISSION; ANIMAL; C57BL MOUSE; CELL MOTION; CHILD; CYTOLOGY; GENE TRANSFER; GENETICS; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; SYNAPSE; ULTRASTRUCTURE;

ANIMALS; AUTISTIC DISORDER; CELL ADHESION; CELL MOVEMENT; CEREBELLUM; CHILD; CHILD, PRESCHOOL; DENDRITIC SPINES; GENE TRANSFER TECHNIQUES; HUMANS; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; NEURONS; RECOMBINANT FUSION PROTEINS; SYNAPSES;

EID: 79956040296     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-52     Document Type: Article

References (55)

1. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008, 9:341-355. 10.1038/nrg2346, 2756414, 18414403.
2. Weiss LA. Autism genetics: emerging data from genome-wide copy-number and single nucleotide polymorphism scans. Expert Rev Mol Diagn 2009, 9:795-803. 10.1586/erm.09.59, 19895225.
3. Buxbaum JD, Baron-Cohen S, Devlin B. Genetics in psychiatry: common variant association studies. Mol Autism 2010, 1:6. 10.1186/2040-2392-1-6, 2907568, 20678248.
4. Devlin B, Melhem N, Roeder K. Do common variants play a role in risk for autism? Evidence and theoretical musings. Brain Res 2010,
5. Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, Malik M. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009, 207:111-116. 10.1016/j.jneuroim.2008.12.002, 2770268, 19157572.
6. Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P, Altaye M, Wills-Karp M. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 2006, 172:198-205. 10.1016/j.jneuroim.2005.11.007, 16360218.
7. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57:67-81. 10.1002/ana.20315, 15546155.
8. Sheikh AM, Li X, Wen G, Tauqeer Z, Brown WT, Malik M. Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects. Neuroscience 2010, 165:363-370. 10.1016/j.neuroscience.2009.10.035, 19854241.
9. Malik M, Sheikh AM, Wen G, Spivack W, Brown WT, Li X. Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiology 2011, 216:80-85. 10.1016/j.imbio.2010.03.001, 20399529.
10. Sheikh AM, Malik M, Wen G, Chauhan A, Chauhan V, Gong CX, Liu F, Brown WT, Li X. BDNF-Akt-Bcl2 antiapoptotic signaling pathway is compromised in the brain of autistic subjects. J Neurosci Res 2010, 88:2641-2647.
11. Rose-John S, Scheller J, Elson G, Jones SA. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 2006, 80:227-236. 10.1189/jlb.1105674, 16707558.
12. Boulanger LM. Immune proteins in brain development and synaptic plasticity. Neuron 2009, 64:93-109. 10.1016/j.neuron.2009.09.001, 19840552.
13. Van Wagoner NJ, Benveniste EN. Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol 1999, 100:124-139. 10.1016/S0165-5728(99)00187-3, 10695723.
14. Gruol DL, Nelson TE. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997, 15:307-339. 10.1007/BF02740665, 9457704.
15. Gadient RA, Otten UH. Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997, 52:379-390. 10.1016/S0301-0082(97)00021-X, 9304698.
16. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990, 8:253-278. 10.1146/annurev.iy.08.040190.001345, 2188664.
17. Vallieres L, Campbell IL, Gage FH, Sawchenko PE. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci 2002, 22:486-492.
18. Nakanishi M, Niidome T, Matsuda S, Akaike A, Kihara T, Sugimoto H. Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells. Eur J Neurosci 2007, 25:649-658. 10.1111/j.1460-9568.2007.05309.x, 17328769.
19. Oh J, McCloskey MA, Blong CC, Bendickson L, Nilsen-Hamilton M, Sakaguchi DS. Astrocyte-derived interleukin-6 promotes specific neuronal differentiation of neural progenitor cells from adult hippocampus. J Neurosci Res 2010, 88:2798-2809.
20. Ashwood P, Wakefield AJ. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol 2006, 173:126-134. 10.1016/j.jneuroim.2005.12.007, 16494951.
21. Jyonouchi H, Sun S, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001, 120:170-179. 10.1016/S0165-5728(01)00421-0, 11694332.
22. Jyonouchi H, Sun S, Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 2002, 46:76-84. 10.1159/000065416, 12378124.
23. Singh VK. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol 1996, 66:143-145. 10.1016/0165-5728(96)00014-8, 8964908.
24. Croonenberghs J, Bosmans E, Deboutte D, Kenis G, Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology 2002, 45:1-6.
25. El Idrissi A, Trenkner E. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 1999, 19:9459-9468.
26. Hering H, Lin CC, Sheng M. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci 2003, 23:3262-3271.
27. McKinney BC, Grossman AW, Elisseou NM, Greenough WT. Dendritic spine abnormalities in the occipital cortex of C57BL/6 Fmr1 knockout mice. Am J Med Genet B Neuropsychiatr Genet 2005, 136B:98-102. 10.1002/ajmg.b.30183, 15892134.
28. Hozumi Y, Watanabe M, Otani K, Goto K. Diacylglycerol kinase beta promotes dendritic outgrowth and spine maturation in developing hippocampal neurons. BMC Neurosci 2009, 10:99. 10.1186/1471-2202-10-99, 19691842.
29. Wiens KM, Lin H, Liao D. Rac1 induces the clustering of AMPA receptors during spinogenesis. J Neurosci 2005, 25:10627-10636. 10.1523/JNEUROSCI.1947-05.2005, 16291935.
30. Gschwind M, Huber G. Apoptotic cell death induced by beta-amyloid 1-42 peptide is cell type dependent. J Neurochem 1995, 65:292-300.
31. Lizard G, Fournel S, Genestier L, Dhedin N, Chaput C, Flacher M, Mutin M, Panaye G, Revillard JP. Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. Cytometry 1995, 21:275-283. 10.1002/cyto.990210308, 8582250.
32. Jiang Q, Wu Y, Wang J, Wu X, Qin J, Jiang Y. Characterization of developing rat cortical neurons after epileptiform discharges. Int J Dev Neurosci 2010, 28:455-463. 10.1016/j.ijdevneu.2010.06.006, 20600787.
33. Valiente M, Marin O. Neuronal migration mechanisms in development and disease. Curr Opin Neurobiol 2010, 20:68-78. 10.1016/j.conb.2009.12.003, 20053546.
34. Lamszus K, Schmidt NO, Jin L, Laterra J, Zagzag D, Way D, Witte M, Weinand M, Goldberg ID, Westphal M, Rosen EM. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer 1998, 75:19-28. 10.1002/(SICI)1097-0215(19980105)75:1<19::AID-IJC4>3.0.CO;2-4, 9426685.
35. Luo J. Mechanisms of Ethanol-Induced Death of Cerebellar Granule Cells. Cerebellum 2010,
36. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991, 66:233-243. 10.1016/0092-8674(91)90614-5, 1713127.
37. Lin JK, Chou CK. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor beta 1. Cancer Res 1992, 52:385-388.
38. Novelli F, Di Pierro F, Francia di Celle P, Bertini S, Affaticati P, Garotta G, Forni G. Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. J Immunol 1994, 152:496-504.
39. Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994, 179:873-879. 10.1084/jem.179.3.873, 2191418, 7509364.
40. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J 1996, 15:3861-3870. 452079, 8670891.
41. Bink K, Walch A, Feuchtinger A, Eisenmann H, Hutzler P, Hofler H, Werner M. TO-PRO-3 is an optimal fluorescent dye for nuclear counterstaining in dual-colour FISH on paraffin sections. Histochem Cell Biol 2001, 115:293-299.
42. Suzuki T, Fujikura K, Higashiyama T, Takata K. DNA staining for fluorescence and laser confocal microscopy. J Histochem Cytochem 1997, 45:49-53. 10.1177/002215549704500107, 9010468.
43. Rubenstein JL, Merzenich MM. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2003, 2:255-267. 10.1034/j.1601-183X.2003.00037.x, 14606691.
44. Chez MG, Dowling T, Patel PB, Khanna P, Kominsky M. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol 2007, 36:361-365. 10.1016/j.pediatrneurol.2007.01.012, 17560496.
45. Hatten ME. Central nervous system neuronal migration. Annu Rev Neurosci 1999, 22:511-539. 10.1146/annurev.neuro.22.1.511, 10202547.
46. Schmid RS, Shelton S, Stanco A, Yokota Y, Kreidberg JA, Anton ES. alpha3beta1 integrin modulates neuronal migration and placement during early stages of cerebral cortical development. Development 2004, 131:6023-6031. 10.1242/dev.01532, 15537685.
47. Stanco A, Szekeres C, Patel N, Rao S, Campbell K, Kreidberg JA, Polleux F, Anton ES. Netrin-1-alpha3beta1 integrin interactions regulate the migration of interneurons through the cortical marginal zone. Proc Natl Acad Sci USA 2009, 106:7595-7600. 10.1073/pnas.0811343106, 2678634, 19383784.
48. Wei H, Malik M, Sheikh AM, Merz G, Brown WT, Li X. Abnormal cell properties and down-regulated FAK-Src complex signaling in B lymphoblasts of autistic subjects. American Journal of Pathology 2011,
49. Araghi-Niknam M, Fatemi SH. Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Cell Mol Neurobiol 2003, 23:945-952.
50. McAllister AK. Dynamic aspects of CNS synapse formation. Annu Rev Neurosci 2007, 30:425-450. 10.1146/annurev.neuro.29.051605.112830, 17417940.
51. Sudhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911. 10.1038/nature07456, 2673233, 18923512.
52. Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007, 8:101-112. 10.1038/nrm2101, 17245412.
53. Kim HG, Kishikawa S, Higgins AW, Seong IS, Donovan DJ, Shen Y, Lally E, Weiss LA, Najm J, Kutsche K, Descartes M, Holt L, Braddock S, Troxell R, Kaplan L, Volkmar F, Klin A, Tsatsanis K, Harris DJ, Noens I, Pauls DL, Daly MJ, MacDonald ME, Morton CC, Quade BJ, Gusella JF. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 2008, 82:199-207. 10.1016/j.ajhg.2007.09.011, 2253961, 18179900.
54. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsater H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Roge B, Heron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007, 39:25-27. 10.1038/ng1933, 2082049, 17173049.
55. Bozdagi O, Sakurai T, Papapetrou D, Wang X, Dickstein DL, Takahashi N, Kajiwara Y, Yang M, Katz AM, Scattoni ML, Harris MJ, Saxena R, Silverman JL, Crawley JN, Zhou Q, Hof PR, Buxbaum JD. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol Autism 2010, 1:15. 10.1186/2040-2392-1-15, 3019144, 21167025.